| Year |
Citation |
Score |
| 2023 |
Habault J, Schneider JA, Ha S, Ruoff R, Doro Pereira LD, Puccini J, Ranieri M, Ayasun R, Deng J, Kasper AC, Bar-Sagi D, Wong KK, Zoubeidi A, Claessens F, Wise DR, ... Logan SK, et al. A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer. Molecular Cancer Therapeutics. PMID 37486978 DOI: 10.1158/1535-7163.MCT-23-0196 |
0.54 |
|
| 2021 |
Ruff SE, Vasilyev N, Nudler E, Logan SK, Garabedian MJ. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer. Communications Biology. 4: 1221. PMID 34697370 DOI: 10.1038/s42003-021-02723-9 |
0.534 |
|
| 2021 |
Briggs EM, Mita P, Sun X, Ha S, Vasilyev N, Leopold ZR, Nudler E, Boeke JD, Logan SK. Unbiased proteomic mapping of the LINE-1 promoter using CRISPR Cas9. Mobile Dna. 12: 21. PMID 34425899 DOI: 10.1186/s13100-021-00249-9 |
0.752 |
|
| 2021 |
Briggs EM, McKerrow W, Mita P, Boeke JD, Logan SK, Fenyö D. RIP-seq reveals LINE-1 ORF1p association with p-body enriched mRNAs. Mobile Dna. 12: 5. PMID 33563338 DOI: 10.1186/s13100-021-00233-3 |
0.781 |
|
| 2021 |
Ledet RJ, Ruff SE, Wang Y, Nayak S, Schneider JA, Ueberheide B, Logan SK, Garabedian MJ. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion. Communications Biology. 4: 36. PMID 33398037 DOI: 10.1038/s42003-020-01528-6 |
0.504 |
|
| 2020 |
Wise DR, Schneider JA, Armenia J, Febles VA, McLaughlin B, Brennan R, Thoren KL, Abida W, Sfanos KS, De Marzo AM, Yegnasubramanian S, Fox JJ, Haas M, Heath H, Kagey MH, ... ... Logan SK, et al. Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer. Jco Precision Oncology. 4. PMID 33015525 DOI: 10.1200/PO.20.00097 |
0.484 |
|
| 2020 |
Ruff SE, Logan SK, Garabedian MJ, Huang TT. Roles for MDC1 in cancer development and treatment. Dna Repair. 95: 102948. PMID 32866776 DOI: 10.1016/J.Dnarep.2020.102948 |
0.386 |
|
| 2020 |
Thomas PA, Schafler ED, Ruff SE, Voisin M, Ha S, Logan SK. UXT in Sertoli Cells is Required for Blood-Testis Barrier Integrity. Biology of Reproduction. PMID 32678429 DOI: 10.1093/Biolre/Ioaa121 |
0.35 |
|
| 2019 |
Briggs EM, Spadafora C, Logan SK. A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells. Mobile Dna. 10: 51. PMID 31890047 DOI: 10.1186/S13100-019-0196-X |
0.541 |
|
| 2019 |
Wang Y, Schafler ED, Thomas PA, Ha S, David G, Adney E, Garabedian MJ, Lee P, Logan SK. Prostate-specific loss of UXT promotes cancer progression. Oncotarget. 10: 707-716. PMID 30774773 DOI: 10.18632/Oncotarget.26573 |
0.599 |
|
| 2018 |
Thomas PA, Mita P, Ha S, Logan SK. Role of the Unconventional Prefoldin Proteins URI and UXT in Transcription Regulation. Advances in Experimental Medicine and Biology. 1106: 85-94. PMID 30484154 DOI: 10.1007/978-3-030-00737-9_6 |
0.811 |
|
| 2018 |
Schneider JA, Craven TW, Kasper AC, Yun C, Haugbro M, Briggs EM, Svetlov V, Nudler E, Knaut H, Bonneau R, Garabedian MJ, Kirshenbaum K, Logan SK. Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer. Nature Communications. 9: 4396. PMID 30352998 DOI: 10.1038/S41467-018-06845-3 |
0.487 |
|
| 2018 |
Schafler ED, Thomas PA, Ha S, Wang Y, Bermudez-Hernandez K, Tang Z, Fenyö D, Vigodner M, Logan SK. UXT is required for spermatogenesis in mice. Plos One. 13: e0195747. PMID 29649254 DOI: 10.1371/Journal.Pone.0195747 |
0.331 |
|
| 2018 |
Briggs EM, Ha S, Mita P, Brittingham G, Sciamanna I, Spadafora C, Logan SK. Long interspersed nuclear element-1 expression and retrotransposition in prostate cancer cells. Mobile Dna. 9: 1. PMID 29308092 DOI: 10.1186/S13100-017-0106-Z |
0.816 |
|
| 2017 |
Bainor AJ, Deng FM, Wang Y, Lee P, Cantor DJ, Logan SK, David G. Chromatin-associated protein SIN3B prevents prostate cancer progression by inducing senescence. Cancer Research. PMID 28807943 DOI: 10.1158/0008-5472.Can-16-3410 |
0.544 |
|
| 2017 |
Schneider JA, Logan SK. Revisiting the role of Wnt/β-catenin signaling in prostate cancer. Molecular and Cellular Endocrinology. PMID 28189566 DOI: 10.1016/J.Mce.2017.02.008 |
0.534 |
|
| 2016 |
Mita P, Savas JN, Briggs EM, Ha S, Gnanakkan V, Yates JR, Robins DM, David G, Boeke JD, Garabedian MJ, Logan SK. URI Regulates KAP1 Phosphorylation and Transcriptional Repression Via PP2A Phosphatase in Prostate Cancer Cells. The Journal of Biological Chemistry. PMID 27780869 DOI: 10.1074/Jbc.M116.741660 |
0.817 |
|
| 2016 |
Wang Y, Dehigaspitiya DC, Levine PM, Profit AA, Haugbro M, Imberg-Kazdan K, Logan SK, Kirshenbaum K, Garabedian MJ. Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation. Cancer Research. PMID 27488525 DOI: 10.1158/0008-5472.Can-16-0385 |
0.598 |
|
| 2016 |
Wang Y, Ledet RJ, Imberg-Kazdan K, Logan SK, Garabedian MJ. Dynein axonemal heavy chain 8 promotes androgen receptor activity and associates with prostate cancer progression. Oncotarget. PMID 27363033 DOI: 10.18632/Oncotarget.10284 |
0.619 |
|
| 2016 |
Wang Y, Levine P, Dehigaspitiya D, Profit A, Logan S, Imberg-Kazdan K, Kirshenbaum K, Garabedian M. Abstract 4852: Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation Cancer Research. 76: 4852-4852. DOI: 10.1158/1538-7445.Am2016-4852 |
0.586 |
|
| 2016 |
Ledet R, Logan S, Garabedian M. MP84-12 COMBATTING AR N-TERMINAL VARIANT-DRIVEN ENZALUTAMIDE RESISTANT PROSTATE CANCER BY TARGETING THE KINASE HIPK2 Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2236 |
0.516 |
|
| 2016 |
Bainor A, Wang Y, Lee P, Logan S, David G. MP66-03 THE CHROMATIN ASSOCIATED SIN3B PROTEIN RESTRICTS PROSTATE CANCER PROGRESSION. Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1277 |
0.562 |
|
| 2015 |
Lee E, Ha S, Logan SK. Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. Plos One. 10: e0141589. PMID 26509262 DOI: 10.1371/Journal.Pone.0141589 |
0.823 |
|
| 2015 |
Lee E, Ha S, Logan S. MP66-08 DUAL PATHWAY INHIBITION IN PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2361 |
0.807 |
|
| 2014 |
Daniels G, Jha R, Shen Y, Logan SK, Lee P. Androgen receptor coactivators that inhibit prostate cancer growth. American Journal of Clinical and Experimental Urology. 2: 62-70. PMID 25374906 |
0.525 |
|
| 2014 |
Daniels G, Li Y, Gellert LL, Zhou A, Melamed J, Wu X, Zhang X, Zhang D, Meruelo D, Logan SK, Basch R, Lee P. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth. Endocrine-Related Cancer. 21: 127-42. PMID 24243687 DOI: 10.1530/Erc-13-0293 |
0.562 |
|
| 2014 |
Guerrero A, Ruoff R, Gavila J, Logan S, Gozlabo F, Climent Duran MA, Guillem V, Muggia F, Ruiz A. Changes in androgen receptor (AR) expression and its phosphorylated isoforms, in breast cancer (BC) patients treated with neoadjuvant letrozole. Journal of Clinical Oncology. 32: 541-541. DOI: 10.1200/Jco.2014.32.15_Suppl.541 |
0.417 |
|
| 2014 |
Mita P, Logan S. MP31-02 REGULATION OF GENOMIC STABILITY IN PROSTATE CANCER Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.911 |
0.818 |
|
| 2014 |
Daniels G, Li Y, Gellert LL, Melamed J, Wu X, Zhang D, Meruelo D, Logan S, Basch R, Lee P. MP49-04 ROLE OF NUCLEAR AND CYTOPLASMIC TBLR1 IN PROSTATE CANCER Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1105 |
0.564 |
|
| 2013 |
Staverosky JA, Zhu XH, Ha S, Logan SK. Anti-androgen resistance in prostate cancer cells chronically induced by interleukin-1β. American Journal of Clinical and Experimental Urology. 1: 53-65. PMID 25374900 |
0.817 |
|
| 2013 |
Daniels G, Pei Z, Logan SK, Lee P. Mini-review: androgen receptor phosphorylation in prostate cancer. American Journal of Clinical and Experimental Urology. 1: 25-9. PMID 25374897 |
0.48 |
|
| 2013 |
Akinyeke T, Matsumura S, Wang X, Wu Y, Schalfer ED, Saxena A, Yan W, Logan SK, Li X. Metformin targets c-MYC oncogene to prevent prostate cancer. Carcinogenesis. 34: 2823-32. PMID 24130167 DOI: 10.1093/Carcin/Bgt307 |
0.566 |
|
| 2013 |
Lee E, Madar A, David G, Garabedian MJ, Dasgupta R, Logan SK. Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: 15710-5. PMID 24019458 DOI: 10.1073/Pnas.1218168110 |
0.827 |
|
| 2013 |
Mita P, Savas JN, Ha S, Djouder N, Yates JR, Logan SK. Analysis of URI nuclear interaction with RPB5 and components of the R2TP/prefoldin-like complex. Plos One. 8: e63879. PMID 23667685 DOI: 10.1371/Journal.Pone.0063879 |
0.784 |
|
| 2013 |
Ren Q, Zhang L, Ruoff R, Ha S, Wang J, Jain S, Reuter V, Gerald W, Giri DD, Melamed J, Garabedian MJ, Lee P, Logan SK. Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer. 119: 2532-40. PMID 23605249 DOI: 10.1002/Cncr.28092 |
0.348 |
|
| 2013 |
Imberg-Kazdan K, Ha S, Greenfield A, Poultney CS, Bonneau R, Logan SK, Garabedian MJ. A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells. Genome Research. 23: 581-91. PMID 23403032 DOI: 10.1101/Gr.144774.112 |
0.582 |
|
| 2013 |
Ha S, Iqbal NJ, Mita P, Ruoff R, Gerald WL, Lepor H, Taneja SS, Lee P, Melamed J, Garabedian MJ, Logan SK. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer. Oncogene. 32: 3992-4000. PMID 22986532 DOI: 10.1038/Onc.2012.412 |
0.827 |
|
| 2013 |
Zhu X, Staverosky J, Logan S. Anti-androgen resistance in prostate cancer cells induced by IL-1β. Journal of Clinical Oncology. 31: e16057-e16057. DOI: 10.1200/Jco.2013.31.15_Suppl.E16057 |
0.799 |
|
| 2013 |
Kirshenbaum K, Levine P, Lee E, Imberg-Kazdan K, Logan S, Garabedian M. 981 TARGETING ANDROGEN RECEPTOR-DEPENDENT PROSTATE CANCER WITH MULTIVALENT ETHISTERONE CONJUGATES Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.563 |
0.833 |
|
| 2013 |
Lee E, Garabedian M, DasGupta R, Logan S. 796 INHIBITION OF ANDROGEN RECEPTOR AND BETA-CATENIN ACTIVITY IN PROSTATE CANCER Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.360 |
0.803 |
|
| 2012 |
Levine PM, Lee E, Greenfield A, Bonneau R, Logan SK, Garabedian MJ, Kirshenbaum K. Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells. Acs Chemical Biology. 7: 1693-701. PMID 22871957 DOI: 10.1021/Cb300332W |
0.817 |
|
| 2012 |
Ligr M, Li Y, Logan SK, Taneja S, Melamed J, Lepor H, Garabedian MJ, Lee P. Mifepristone inhibits GRβ coupled prostate cancer cell proliferation. The Journal of Urology. 188: 981-8. PMID 22819113 DOI: 10.1016/J.Juro.2012.04.102 |
0.599 |
|
| 2011 |
Mita P, Savas JN, Djouder N, Yates JR, Ha S, Ruoff R, Schafler ED, Nwachukwu JC, Tanese N, Cowan NJ, Zavadil J, Garabedian MJ, Logan SK. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP. Molecular and Cellular Biology. 31: 3639-52. PMID 21730289 DOI: 10.1128/Mcb.05429-11 |
0.836 |
|
| 2011 |
Wu X, Daniels G, Shapiro E, Xu K, Huang H, Li Y, Logan S, Greco MA, Peng Y, Monaco ME, Melamed J, Lepor H, Grishina I, Lee P. LEF1 identifies androgen-independent epithelium in the developing prostate. Molecular Endocrinology (Baltimore, Md.). 25: 1018-26. PMID 21527502 DOI: 10.1210/me.2010-0513 |
0.45 |
|
| 2011 |
Ha S, Ruoff R, Kahoud N, Franke TF, Logan SK. Androgen receptor levels are upregulated by Akt in prostate cancer. Endocrine-Related Cancer. 18: 245-55. PMID 21317204 DOI: 10.1530/ERC-10-0204 |
0.498 |
|
| 2010 |
Logan S, Mita P, Schafler E, Garabedian M. 1294 A TRANSCRIPTION REPRESSOR COMPLEX CRITICAL FOR ANTI-ANDROGEN ACTION Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.878 |
0.778 |
|
| 2010 |
Garabedian M, Imberg K, Ha S, Logan S. 549 GENOME WIDE ANALYSIS OF FACTORS AFFECTING ANDROGEN RECEPTOR FUNCTION REVEALS NEW THERAPEUTIC TARGETS IN PROSTATE CANCER Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.769 |
0.551 |
|
| 2009 |
Nwachukwu JC, Mita P, Ruoff R, Ha S, Wang Q, Huang SJ, Taneja SS, Brown M, Gerald WL, Garabedian MJ, Logan SK. Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Research. 69: 3140-7. PMID 19318562 DOI: 10.1158/0008-5472.CAN-08-3738 |
0.841 |
|
| 2009 |
Torra IP, Staverosky JA, Ha S, Logan SK, Garabedian MJ. Development of phosphorylation site-specific antibodies to nuclear receptors. Methods in Molecular Biology (Clifton, N.J.). 505: 221-35. PMID 19117148 DOI: 10.1007/978-1-60327-575-0_13 |
0.755 |
|
| 2008 |
Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ. Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Research. 68: 3601-8. PMID 18483241 DOI: 10.1158/0008-5472.Can-08-0073 |
0.581 |
|
| 2008 |
Shapiro E, Huang H, Ruoff R, Lee P, Tanese N, Logan SK. The heterochromatin protein 1 family is regulated in prostate development and cancer. The Journal of Urology. 179: 2435-9. PMID 18436254 DOI: 10.1016/J.Juro.2008.01.091 |
0.548 |
|
| 2008 |
Logan SK, Nwachukwu JC, Mita P, Taneja SS, Garabedian MJ. REGULATION OF PROSTATE CELL GROWTH THROUGH ANDROGEN RECEPTOR COFACTORS Journal of Urology. 179: 190-190. DOI: 10.1016/S0022-5347(08)60552-2 |
0.818 |
|
| 2007 |
Nwachukwu JC, Li W, Pineda-Torra I, Huang HY, Ruoff R, Shapiro E, Taneja SS, Logan SK, Garabedian MJ. Transcriptional regulation of the androgen receptor cofactor androgen receptor trapped clone-27. Molecular Endocrinology (Baltimore, Md.). 21: 2864-76. PMID 17761951 DOI: 10.1210/Me.2007-0094 |
0.53 |
|
| 2005 |
Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J, Shapiro E, Garabedian MJ, Logan SK. Cell-specific regulation of androgen receptor phosphorylation in vivo. The Journal of Biological Chemistry. 280: 40916-24. PMID 16210317 DOI: 10.1074/Jbc.M508442200 |
0.474 |
|
| 2005 |
Li W, Cavasotto CN, Cardozo T, Ha S, Dang T, Taneja SS, Logan SK, Garabedian MJ. Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function. Molecular Endocrinology (Baltimore, Md.). 19: 2273-82. PMID 15919721 DOI: 10.1210/Me.2005-0134 |
0.565 |
|
| 2004 |
Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK. ART-27, an androgen receptor coactivator regulated in prostate development and cancer. The Journal of Biological Chemistry. 279: 13944-52. PMID 14711828 DOI: 10.1074/Jbc.M306576200 |
0.616 |
|
| 2002 |
Markus SM, Taneja SS, Logan SK, Li W, Ha S, Hittelman AB, Rogatsky I, Garabedian MJ. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Molecular Biology of the Cell. 13: 670-82. PMID 11854421 DOI: 10.1091/Mbc.01-10-0513 |
0.528 |
|
| 1998 |
Rogatsky I, Logan SK, Garabedian MJ. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase Proceedings of the National Academy of Sciences of the United States of America. 95: 2050-2055. PMID 9482836 DOI: 10.1073/Pnas.95.5.2050 |
0.363 |
|
| Show low-probability matches. |